Rnr F Stock Analysis Renaissancere 5.75 Pct Series F Dep Pref Shares Flat At 100 20260403 Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress NCSM Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Rise WBD Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress in Turnaround DHCNI Q1 2026 Earnings EPS Miss Amid Challenging Operating Environment WAB Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain GBDC Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions